The global veterinary/animal vaccines market has been segmented into type, and technology.
Based on type, the veterinary/animal vaccines market has been segmented into livestock vaccines, porcine vaccines, companion animal vaccines, poultry vaccines, and aquaculture vaccines. The livestock vaccines segment was the largest segment of the veterinary/animal vaccines market in 2017, valued at USD 1,558.94 million in 2017.
On the basis of technology, the global veterinary/animal vaccines market has been segmented into live attenuated vaccine, inactivated vaccines, recombinant vaccines, and toxoid vaccines.
Get Premium Free Sample Report at https://www.marketresearchfuture.com/sample_request/2687
Growth Factors and Key Restraints:
Animal vaccines are the best option for controlling transmission diseases, offering protection to not just the animals but to the human health as well, a highly crucial factor when it comes to the public dependency on animals. As animals are the primary source of meat, food, protein, milk, and various other commercial products like wool and leather, their wellbeing is essential to the economy. The veterinary vaccines that have the most common use are foot & mouth diseases vaccines, equine influenza virus vaccines and rabies vaccines, which are known for preventing the transmission of infectious agents as these are similar to the naturally acquired immunity.
The continuous advancement of vaccines goes hand in hand with the emergence of a variety of animal diseases, in terms of curbing them, which many of the research centers and other medical institutes are currently working on. Also, the growth in pet ownership has given a substantial push to the growth of the market in recent years.
On that note, the growth of the animal vaccines market is expected to be steady in the coming years as a result of the rise in the pet ownership in emerging countries along with the surging number of cattle & poultry in these economies around the world. In addition, the expanding investment for research and development (R&D) of vaccines that curb the growth of antibiotic-resistant organisms is poised to bring lucrative results for the animal vaccines market in the foreseeable future. To illustrate, Elanco had made an investment of about two-thirds of the budget for food‐animal unit in 2016, for the development of vaccines as well as for bringing down the use of antibiotics. Apart from this, the growing demand for animal vaccines is giving rise to companies introducing a variety of new vaccines. Citing a reference, in February 2017, Cevac IBron had been developed by Ceva which protects the animal against infectious bronchitis virus (IBV).
But with the abysmal awareness levels regarding animal health, the animal vaccine market could take a hit during the review period. Nevertheless, the ongoing advancements in vaccine products and the hike in the production of animal vaccines, particularly for hybrid animals are predicted to ensure that market has a smooth run over the years to come.
The prominent vendors competing within the global veterinary/animal vaccines market include IDT Biologika GmbH (Germany), MSD & Co. Inc (US), Zoetis (US), Virbac (France), Ceva (US), Elanco (US), Boehringer Ingelheim International GmbH (Germany), Biogenesis Bago SA (Argentina), Phibro Animal Health Corporation (US), Hipra (Spain), and others.
May 2019: Brilliant Bophirima (India) is set to expand its animal vaccine portfolio, by making huge investments to increase its focus on animal health by offering nutrition-dense products, along with various other medication-based products in the offered range.
Browse Complete 133 Pages Premium Research Report Enabled With Respective Tables And Figures At https://www.marketresearchfuture.com/reports/mea-veterinary-vaccines-market-2687
The global veterinary/animal vaccines market, based on region, is divided into the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas is on track to be the leading market in the worldwide veterinary/animal vaccines market, as the region has high potential that could influence the trends of the animal vaccines market. The growth in pet ownership as well as the increasing incidence of various zoonotic diseases has brought about this transformation in the market dynamics in the region. In addition to this, the continuous research based on cutting-edge vaccine production technology has had a boost in recent times owing to the heightened demand for animal-based food products along with companion animals.
Growing at the fastest rate, Asia Pacific is one of the prominent regions within the global veterinary/animal vaccines market on account of the augmented efforts by non-governmental organizations for the welfare of animals, elevated number of private veterinary clinics, growing awareness regarding animal welfare, and rising penetration of the veterinary sector.
The Europe market benefits from factors like the expanding livestock population and subsequent increase in the breakouts of livestock diseases; surge in the adoption rate of companion animals; growing initiatives by a number of government agencies, rising incidence of zoonotic diseases; and emergence of the latest types of vaccines within the region.
Finally, the least share has been accrued by the Middle East & Africa in the global veterinary/animal vaccines market, owing to lack of technological advancements and disinterest in animal welfare. However, the growth of the market in Saudi Arabia is expected to be substantial during the evaluation period as a result of the rising number of pet owners, burgeoning livestock population and the sharp rise in disease outbreaks.
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar